✦ LIBER ✦

A polymorphism ofEGFRextracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment

✍ Scribed by Anthony Gonçalves; Séverine Esteyries; Brynn Taylor-Smedra; Arnaud Lagarde; Mounay Ayadi; Geneviève Monges; François Bertucci; Benjamin Esterni; Jean-Robert Delpero; Olivier Turrini; Bernard Lelong; Patrice Viens; Jean-Paul Borg; Daniel Birnbaum; Sylviane Olschwang; Frédéric Viret

Book ID: 115011280
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 564 KB
Volume: 8
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-8-169

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Genetic Polymorphisms Associated Wit

Re: Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib

✍ Taneja, Samir S. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 88 KB

Pharmacogenetic profiling of CD133 is as

Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy

✍ Pohl, A; El-Khoueiry, A; Yang, D; Zhang, W; Lurje, G; Ning, Y; Winder, T; Hu-Lie 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 401 KB

Human epidermal growth factor receptor 2

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy

✍ Allan Lipton; Kim Leitzel; Suhail M. Ali; Walter Carney; Greg Platek; Klaudia St 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

P115. Association between the EGFR-R497K

P115. Association between the EGFR-R497K polymorphism and overall survival in patients with advanced cancer of the head and neck receiving cetuximab based treatment

✍ J. Stoehlmacher; S. Lehmann; L. Obermann; G. Ehninger; E. Goekkurt 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

The miR-200 family controls -tubulin III

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

✍ Leskela, S.; Leandro-Garcia, L. J.; Mendiola, M.; Barriuso, J.; Inglada-Perez, L 📂 Article 📅 2010 🏛 Bioscientifica 🌐 English ⚖ 285 KB